Inhibitory effects of α-arbutin on melanin synthesis in cultured human melanoma cells and a three-dimensional human skin model

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 4, 2004, Pages 510-514

  Sugimoto, Kazuhisa ^a   Nishimura, Takahisa ^a   Nomura, Koji ^a   Sugimoto, Kenji ^a   Kuriki, Takashi ^b  

^a EZAKI GLICO CO LTD   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

arbutin; Human melanoma cell; Human tyrosinase; Inhibition; Melanin; Three dimensional human skin model

Indexed keywords

ALPHA ARBUTIN; GLUCOSIDE; MELANIN; UNCLASSIFIED DRUG; ARBUTIN; ENZYME INHIBITOR; MONOPHENOL MONOOXYGENASE;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; MELANOGENESIS; MELANOMA CELL; MICROSCOPY; NUCLEOTIDE SEQUENCE; PIGMENTATION; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; DRUG ANTAGONISM; GENETICS; MELANOMA; METABOLISM; ORGAN CULTURE TECHNIQUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN;

ARBUTIN; CELL DIVISION; ENZYME INHIBITORS; HUMANS; MELANINS; MELANOMA; MODELS, BIOLOGICAL; MONOPHENOL MONOOXYGENASE; ORGAN CULTURE TECHNIQUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; TUMOR CELLS, CULTURED;

EID: 16544380009     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.510     Document Type: Article

References (19)

1. Nishimura T., Kometani T., Takii H., Terada Y., Okada S., J. Ferment. Bioeng., 78, 31-36 (1994).
2. Funayama M., Arakawa H., Yamamoto R., Nishino T., Shin T., Murao S., Biosci. Biotech. Biochem., 59, 143-144 (1995).
3. Kitao S., Sekine H., Biosci. Biotech. Biochem., 58, 38-42 (1994).
4. Kurosu J., Sato T., Yoshida K., Tsugane T., Shimura S., Kirimura K., Kino K., Usami S., J. Biosci. Bioeng., 93, 328-330 (2002).
5. Nishimura T., Kometani T., Okada S., Ueno N., Yamamoto T., Yakugaku Zasshi, 115, 626-632 (1995).
6. Sugimoto K., Nishimura T., Nomura K., Sugimoto K., Kuriki T., Chem. Pharm. Bull., 51, 798-801 (2003).
7. Hasumi K., Sakamoto G., Sugano H., Kasuga T., Masubuchi K., Cancer, 42, 2675-2686 (1978).
8. Hosoi J., Abe E., Suda T., Kuroki T., Cancer Res., 45, 1474-1478 (1985).
9. Tomita Y., Maeda K., Tagami H., Pigment Cell Res., 5, 357-361 (1992).
10. Imai H., J. Saitama Med. School, 29, 35-50 (2002).
11. Maeda K., Fukuda M., J. Pharmacol. Exp. Ther., 276, 765-769 (1996).
12. Nakajima M., Shinoda I., Fukuwatari Y., Hayasawa H., Pigment Cell Res., 11, 12-17 (1998).
13. Chakraborty A. K., Funasaka Y., Komoto M., Ichihashi M., Pigment Cell Res., 11, 206-212 (1993).
14. Yoon T. J., Lei T. C., Yamaguchi Y., Batzer J., Wolber R., Hearing V. J., Anal. Biochem., 318, 260-269 (2003).
15. Majmudar G., Jacob G., Laboy Y., Fisher L., J. Cosmet. Sci., 49, 361-367 (1998).
16. Passi S., Nazzaro-Porro M., Br. J. Dermatol., 104, 659-665 (1981).
17. Jimbou K., Obata H., Pathak M. A., Fitzpatrick T. B., J. Invest. Dermatol., 62, 436-449 (1974).
18. Penny K. B., Smith C. J., Allen J. C., J. Invest. Dermatol., 82, 308-310 (1984).
19. Smith C. J., O'Hare K. B., Allen J. C., Pigment Cell Res., 1, 386-389 (1988).